Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses

Non-replicating rotavirus vaccines are an alternative strategy to improve the efficacy and safety of rotavirus vaccines. The spike protein VP4, which could be enzymatically cleaved into VP8∗ and VP5∗, is an ideal target for the development of recombinant rotavirus vaccine. In our previous studies, w...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Guoxing, Zeng, Yuanjun, Yang, Han, Li, Yijian, Yang, Lianwei, Li, Cao, Song, Feibo, Zhang, Shiyin, Li, Tingdong, Ge, Shengxiang, Zhang, Jun, Xia, Ningshao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519587/
https://www.ncbi.nlm.nih.gov/pubmed/36185383
http://dx.doi.org/10.1016/j.isci.2022.105099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519587/
https://www.ncbi.nlm.nih.gov/pubmed/36185383
http://dx.doi.org/10.1016/j.isci.2022.105099

Ejemplares similares